{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:55:21Z","timestamp":1787774121539,"version":"build-2784847793"},"reference-count":40,"publisher":"BMJ","issue":"6","license":[{"start":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T00:00:00Z","timestamp":1683072000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key R&D Program of China","doi-asserted-by":"crossref","award":["2018YFC1312903"],"award-info":[{"award-number":["2018YFC1312903"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81870905"],"award-info":[{"award-number":["81870905"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U20A20358"],"award-info":[{"award-number":["U20A20358"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Capital\u2019s Funds for Health Improvement and Research","award":["2020-1-2041"],"award-info":[{"award-number":["2020-1-2041"]}]},{"name":"Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences","award":["2019-I2M-5-029"],"award-info":[{"award-number":["2019-I2M-5-029"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Stroke Vasc Neurol"],"accepted":{"date-parts":[[2023,4,3]]},"published-print":{"date-parts":[[2023,12]]},"abstract":"<jats:sec>\n                  <jats:title>Background and purpose<\/jats:title>\n                  <jats:p>The ring finger protein 213 gene (<jats:italic>RNF213<\/jats:italic>) p.R4810K variant increased the risk of acute ischaemic stroke (AIS) attributable to intracranial arterial stenosis (ICAS) in the Japanese and Korean populations. In this study, we aimed to examine the prevalence of the <jats:italic>RNF213<\/jats:italic> p.R4810K variant in Chinese patients with AIS or transient ischaemic attack and identify the phenotype of the carriers.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We analysed data from the Third China National Stroke Registry. All included participants were divided into two groups by carrier status of the p.R4810K variant. The aetiological classification was conducted according to the Trial of Org 10172 in Acute Stroke Treatment (TOAST) criteria. The presence of ICAS and extracranial arterial stenosis (ECAS) was defined as 50%\u201399% stenosis or occlusion of any intracranial and extracranial artery. Logistic regression models and Cox regression models were used to evaluate the association of the p.R4810K variant with TOAST classification, stenosis phenotypes and clinical outcomes.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>A total of 10\u2009381 patients were enrolled, among which 56 (0.5%) had the heterozygote GA genotype for p.R4810K. The variant carriers were younger (p=0.01), and more likely to suffer from peripheral vascular disease (p=0.04). The p.R4810K variant was associated with large-artery atherosclerosis (LAA) (adjusted OR=1.94, 95% CI 1.13\u2009to 3.33), anterior circulation stenosis (adjusted OR=2.12, 95% CI 1.23\u2009to 3.65) and ECAS (adjusted OR=2.29, 95% CI 1.16\u2009to 4.51). Nevertheless, the p.R4810K variant was not associated with recurrence, poor functional outcome and mortality at 3 months and 1\u2009year.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>The <jats:italic>RNF213<\/jats:italic> p.R4810K variant was associated with LAA, anterior circulation stenosis and ECAS in Chinese patients. Given the low carrying rate and only 1-year follow-up information, caution should be taken to interpret our findings in no statistically significant association between the p.R4810K variant and stroke prognosis in Chinese patients.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/svn-2022-002276","type":"journal-article","created":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T10:59:23Z","timestamp":1683111563000},"page":"503-510","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":15,"title":["Detailed phenotype of <i>RNF213<\/i> p.R4810K variant identified by the Chinese patients with acute ischaemic stroke or transient ischaemic attack"],"prefix":"10.1136","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9130-889X","authenticated-orcid":false,"given":"Hongyu","family":"Zhou","sequence":"first","affiliation":[{"name":"Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China"},{"name":"China National Clinical Research Center for Neurological Diseases, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Jing","sequence":"additional","affiliation":[{"name":"Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China"},{"name":"China National Clinical Research Center for Neurological Diseases, Beijing, China"},{"name":"Tiantan Neuroimaging Center of Excellence, Beijing Tiantan Hospital, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9443-2706","authenticated-orcid":false,"given":"Yuehua","family":"Pu","sequence":"additional","affiliation":[{"name":"Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China"},{"name":"China National Clinical Research Center for Neurological Diseases, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China"},{"name":"China National Clinical Research Center for Neurological Diseases, Beijing, China"},{"name":"Monogenic Disease Diagnosis Center for Neurological Disorders and Precision Medicine Research Center for Neurological Disorders, Beijing Tiantan Hospital, Capital Medical University, Beijing, China"},{"name":"Advanced Innovation Center for Human Brain Protection, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Meng","sequence":"additional","affiliation":[{"name":"Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China"},{"name":"China National Clinical Research Center for Neurological Diseases, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anxin","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China"},{"name":"China National Clinical Research Center for Neurological Diseases, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingting","family":"Zuo","sequence":"additional","affiliation":[{"name":"Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China"},{"name":"China National Clinical Research Center for Neurological Diseases, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China"},{"name":"China National Clinical Research Center for Neurological Diseases, Beijing, China"},{"name":"Center of excellence for Omics Research (CORe), Beijing Tiantan Hospital, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8039-709X","authenticated-orcid":false,"given":"Qin","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China"},{"name":"China National Clinical Research Center for Neurological Diseases, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0632-0262","authenticated-orcid":false,"given":"Yue","family":"Suo","sequence":"additional","affiliation":[{"name":"Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China"},{"name":"China National Clinical Research Center for Neurological Diseases, Beijing, China"},{"name":"Tiantan Neuroimaging Center of Excellence, Beijing Tiantan Hospital, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8591-4105","authenticated-orcid":false,"given":"Hao","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China"},{"name":"China National Clinical Research Center for Neurological Diseases, Beijing, China"},{"name":"Center of excellence for Omics Research (CORe), Beijing Tiantan Hospital, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9976-2341","authenticated-orcid":false,"given":"Yongjun","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China"},{"name":"China National Clinical Research Center for Neurological Diseases, Beijing, China"},{"name":"Advanced Innovation Center for Human Brain Protection, Capital Medical University, Beijing, China"},{"name":"Research Unit of Artificial Intelligence in Cerebrovascular Disease, Chinese Academy of Medical Sciences, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2023,5,3]]},"reference":[{"key":"2025082410120199000_8.6.503.1","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.118.024712"},{"key":"2025082410120199000_8.6.503.2","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1007\/s12975-019-00743-6","article-title":"Moyamoya disease and spectrums of RNF213 vasculopathy","volume":"11","author":"Bang","year":"2020","journal-title":"Transl Stroke Res"},{"key":"2025082410120199000_8.6.503.3","doi-asserted-by":"publisher","DOI":"10.1038\/jhg.2010.132"},{"key":"2025082410120199000_8.6.503.4","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000008901"},{"key":"2025082410120199000_8.6.503.5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1105335"},{"key":"2025082410120199000_8.6.503.6","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.112.663864"},{"key":"2025082410120199000_8.6.503.7","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.113.002477"},{"key":"2025082410120199000_8.6.503.8","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.118.038439"},{"key":"2025082410120199000_8.6.503.9","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jns.2017.02.033","article-title":"RNF213 rs112735431 polymorphism in intracranial artery steno-occlusive disease and moyamoya disease in koreans","volume":"375","author":"Park","year":"2017","journal-title":"J Neurol Sci"},{"key":"2025082410120199000_8.6.503.10","doi-asserted-by":"publisher","DOI":"10.1136\/svn-2019-000242"},{"key":"2025082410120199000_8.6.503.11","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.24.1.35"},{"key":"2025082410120199000_8.6.503.12","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1161\/CIRCRESAHA.121.318083","article-title":"Guideline-driven management of hypertension: an evidence-based update","volume":"128","author":"Carey","year":"2021","journal-title":"Circ Res"},{"key":"2025082410120199000_8.6.503.13","doi-asserted-by":"publisher","DOI":"10.2337\/dc22-S002"},{"key":"2025082410120199000_8.6.503.14","doi-asserted-by":"publisher","DOI":"10.2176\/nmc.52.245"},{"key":"2025082410120199000_8.6.503.15","first-page":"643","article-title":"A standardized method for measuring intracranial arterial stenosis","volume":"21","author":"Samuels","year":"2000","journal-title":"AJNR Am J Neuroradiol"},{"key":"2025082410120199000_8.6.503.16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199108153250701"},{"key":"2025082410120199000_8.6.503.17","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.114.007979"},{"key":"2025082410120199000_8.6.503.18","doi-asserted-by":"publisher","DOI":"10.1136\/svn-2020-000352"},{"key":"2025082410120199000_8.6.503.19","doi-asserted-by":"publisher","DOI":"10.1007\/s13258-020-01022-7"},{"key":"2025082410120199000_8.6.503.20","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1161\/STROKEAHA.120.029527","article-title":"Association of genetic variants with moyamoya disease in 13 000 individuals: a meta-analysis","volume":"51","author":"Wang","year":"2020","journal-title":"Stroke"},{"key":"2025082410120199000_8.6.503.21","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s00438-020-01650-4","article-title":"Prevalence of RNF213 variants in symptomatic intracranial arterial stenosis\/occlusion in China","volume":"295","author":"Sun","year":"2020","journal-title":"Mol Genet Genomics"},{"key":"2025082410120199000_8.6.503.22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0022542","article-title":"Identification of Rnf213 as a susceptibility gene for moyamoya disease and its possible role in vascular development","volume":"6","author":"Liu","year":"2011","journal-title":"PLoS ONE"},{"key":"2025082410120199000_8.6.503.23","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.114.006244"},{"key":"2025082410120199000_8.6.503.24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0156607","article-title":"A polymorphism in RNF213 is a susceptibility gene for intracranial atherosclerosis","volume":"11","author":"Bang","year":"2016","journal-title":"PLoS One"},{"key":"2025082410120199000_8.6.503.25","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.116.012751"},{"key":"2025082410120199000_8.6.503.26","doi-asserted-by":"crossref","first-page":"208","DOI":"10.5853\/jos.2018.00150","article-title":"Intracranial large artery disease of non-atherosclerotic origin: recent progress and clinical implications","volume":"20","author":"Bang","year":"2018","journal-title":"J Stroke"},{"key":"2025082410120199000_8.6.503.27","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s12199-017-0680-1","article-title":"Rare variants of RNF213 and moyamoya\/non-moyamoya intracranial artery stenosis\/occlusion disease risk: a meta-analysis and systematic review","volume":"22","author":"Liao","year":"2017","journal-title":"Environ Health Prev Med"},{"key":"2025082410120199000_8.6.503.28","doi-asserted-by":"crossref","first-page":"7908392","DOI":"10.1155\/2019\/7908392","article-title":"The clinical and vascular characteristics of RNF213 c.14576G>A variant-related intracranial major artery disease in China","volume":"2019","author":"Cheng","year":"2019","journal-title":"Behav Neurol"},{"key":"2025082410120199000_8.6.503.29","doi-asserted-by":"crossref","unstructured":"Yamaguchi E , Yoshimoto T , Ogura S , et al . Association of the RNF213 p.R4810K variant with the outer diameter of cervical arteries in patients with ischemic stroke. SVIN 2022;2. doi:10.1161\/SVIN.121.000298","DOI":"10.1161\/SVIN.121.000298"},{"key":"2025082410120199000_8.6.503.30","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(22)00165-X"},{"key":"2025082410120199000_8.6.503.31","doi-asserted-by":"crossref","first-page":"104532","DOI":"10.1016\/j.jstrokecerebrovasdis.2019.104532","article-title":"Can moyamoya disease susceptibility gene affect extracranial systemic artery stenosis?","volume":"29","author":"Nomura","year":"2020","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"2025082410120199000_8.6.503.32","doi-asserted-by":"crossref","first-page":"104786","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.104786","article-title":"De novo renal artery stenosis developed in initially normal renal arteries during the long-term follow-up of patients with moyamoya disease","volume":"29","author":"Hara","year":"2020","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"2025082410120199000_8.6.503.33","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.clineuro.2018.01.034","article-title":"Development of atherosclerotic-moyamoya syndrome with genetic variant of RNF213 p.R4810K and p.T1727M: a case report","volume":"168","author":"Liu","year":"2018","journal-title":"Clin Neurol Neurosurg"},{"key":"2025082410120199000_8.6.503.34","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.1016\/j.jstrokecerebrovasdis.2016.09.035","article-title":"De novo development of moyamoya disease in an adult female with a genetic variant of the RNF-213 gene: case report","volume":"26","author":"Tashiro","year":"2017","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"2025082410120199000_8.6.503.35","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.wneu.2020.04.241","article-title":"Hemorrhagic onset intracranial artery dissection of middle cerebral artery followed by progressive arterial stenosis with genetic variant RNF213 p.Arg4810Lys (rs112735431)","volume":"141","author":"Shinya","year":"2020","journal-title":"World Neurosurg"},{"key":"2025082410120199000_8.6.503.36","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1177\/0271678X20914996","article-title":"Mutations of RNF213 are responsible for sporadic cerebral cavernous malformation and lead to a mulberry-like cluster in zebrafish","volume":"41","author":"Lin","year":"2021","journal-title":"J Cereb Blood Flow Metab"},{"key":"2025082410120199000_8.6.503.37","doi-asserted-by":"publisher","DOI":"10.1097\/WNR.0000000000000289"},{"key":"2025082410120199000_8.6.503.38","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1161\/STROKEAHA.118.021888","article-title":"Cav-1 (caveolin-1) and arterial remodeling in adult moyamoya disease","volume":"49","author":"Chung","year":"2018","journal-title":"Stroke"},{"key":"2025082410120199000_8.6.503.39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0102382","article-title":"Serum miRNA signature in moyamoya disease","volume":"9","author":"Dai","year":"2014","journal-title":"PLoS ONE"},{"key":"2025082410120199000_8.6.503.40","doi-asserted-by":"crossref","unstructured":"Kobayashi H , Matsuda Y , Hitomi T , et al . Biochemical and functional characterization of RNF213 (mysterin) R4810K, a susceptibility mutation of moyamoya disease, in angiogenesis in vitro and in vivo. JAHA 2015;4. doi:10.1161\/JAHA.115.002146","DOI":"10.1161\/JAHA.115.002146"}],"container-title":["Stroke and Vascular Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/svn-2022-002276","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,24]],"date-time":"2025-08-24T17:12:18Z","timestamp":1756055538000},"score":1,"resource":{"primary":{"URL":"https:\/\/svn.bmj.com\/lookup\/doi\/10.1136\/svn-2022-002276"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,3]]},"references-count":40,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,12,29]]},"published-print":{"date-parts":[[2023,12]]}},"alternative-id":["10.1136\/svn-2022-002276"],"URL":"https:\/\/doi.org\/10.1136\/svn-2022-002276","relation":{},"ISSN":["2059-8688","2059-8696"],"issn-type":[{"value":"2059-8688","type":"print"},{"value":"2059-8696","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,3]]}}}